Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(3 sites)
United States
Mayo Clinic in Arizona, Scottsdale, Arizona Mayo Clinic in Florida, Jacksonville, Florida Mayo Clinic, Rochester, Minnesota Age range
18 Years and older
Last updated November 2024